Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Jan 29;110(3):792–803. doi: 10.1016/j.ijrobp.2021.01.033

Table 2.

Summary of Anatomic and Advanced Imaging Volumes Pre- and Post-Radiation

Median Pre-radiation (IQR*) N=23 3-Month Post-RT (IQR) N=19 Change (cc) (IQR) Change (%) (IQR)
Enhancing tumor volume (cc) 16.9 (10.5, 33.5) 10.4 (3.5, 15.6) −3.0 (−9.5, 0.0) −28 (−72, 0)
Hypercellular tumor volume (TV HCV , cc) 6.0 (4.3, 10.8) 1.1 (0.0, 8.6) −3.5 (−5.8, −1.7) −81 (−100, −46)
Hyperperfused tumor volume (TV CBV , cc) 4.5 (1.8, 9.9) 1.1 (0.6, 3.9) −1.4 (−4.3, 0.0) −63 (−87, 0)
Combined Union of TVHCV/TVCBV (cc) 11.4 (6.6, 20.0) 3.0 (1.0, 12.1) −5.0 (−6.9, −0.4) −60 (−88, −2)
Overlap of TVHCV/TVCBV (cc) 0.5 (0.0, 1.1) 0.0 (0.0, 0.2) −0.2 (−0.5, 0.0) −78 (−98, −32)
Non-enhancing TVHCV (cc) 2.1 (1.5, 3.5) 1.4 (0.0, 2.8) −0.7 (−1.9, 0.1) −33 (−90, 4)
Non-enhancing TVCBV (cc) 1.7 (0.6, 2.8) 0.8 (0.5, 1.5) −0.3 (−1.3, 0.2) −30 (−70, 30)
Non-enhancing Union of TVHCV/TVCBV (cc) 3.7 (2.4, 5.9) 2.1 (0.8, 6.0) −1.2 (−2.9, 0.6) −29 (−79, 8)
Non-enhancing Union of TVHCV/TVCBV (%) 35.5 (24.6, 57.4) 52.1 (27.6, 71.4) 3.4 (−6.4, 29.4) 16 (−20, 72)
*

IQR=Interquar le range;

RT=Radia on therapy;

Excluding surgical cavity